![Daniel Camardo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Camardo
Direktor/Vorstandsmitglied bei
CUE BIOPHARMA, INC.
Vermögen: 585 112 $ am 31.07.2026
Profil
Daniel A. Camardo is currently Director at CommunityHealth NFP and will be Director at Cue Biopharma, Inc. starting in 2026.
Formerly, Mr. Camardo was CEO, CFO, Secretary, Director & CAO at Athersys, Inc. from 2022 to 2023; Senior Director-US Commercial Operations at Astellas Pharma US, Inc. from 2003 to 2004; Vice President-Sales & Operations at Clarus Therapeutics, Inc. from 2014 to 2015; and President-US & Executive Vice President at Horizon Therapeutics Ltd. (Ireland) from 2020 to 2022.
Education includes undergraduate studies at Rochester Christian University and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0.52% | 09.07.2026 | 21’800 ( 0.52% ) | 585 112 $ | 31.07.2026 |
Aktive Positionen von Daniel Camardo
| Unternehmen | Position | Beginn |
|---|---|---|
| CUE BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 30.05.2026 |
CommunityHealth NFP
 CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Daniel Camardo
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Vorstandsvorsitzender | 31.12.2023 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.02.2022 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Vertrieb & Marketing | 01.09.2015 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Daniel Camardo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
CommunityHealth NFP
CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
